论文部分内容阅读
我国是乙型肝炎的高发区,全国人群HBV感染率为57.6％。根据我国疾病监测点报告传染病发病数推算,全国每年肝炎发病人数达269万。由于本病的发病机理较为复杂,目前对HBV的治疗效果尚不满意,故本病病程迁延,易转变为慢性肝炎、肝硬变及肝癌。我国每年因患乙型肝炎转变为肝癌而致死者达16万以上。90年代以来,抗病毒治疗主要以干扰素为主,近期有效率30～60％。由于其价格极其昂贵,故有必要对影响其疗效的因素作一探讨。 1 资料与方法 本文观察了220例接受干扰素治疗的慢性乙肝
China is a high incidence of hepatitis B, the national population HBV infection rate was 57.6%. According to the report of disease surveillance in our country, the incidence of infectious diseases is estimated to reach 2.69 million in China each year. As the pathogenesis of this disease is more complex, the current treatment of HBV is not yet satisfactory, so the disease duration of the disease, easy to change into chronic hepatitis, cirrhosis and liver cancer. Every year in our country, more than 160,000 people are dead due to the conversion of hepatitis B to liver cancer. Since the 90s, antiviral therapy is mainly based on interferon, the recent efficiency of 30 to 60%. Because of its extremely expensive price, it is necessary to discuss the factors that affect its efficacy. 1 Materials and Methods This article observed 220 cases of interferon treatment of chronic hepatitis B